More than 2 billion people worldwide currently cannot access the medicines they need, and over 400 million lack access to essential health services. Healthcare access will only be improved if local health system challenges are identified and addressed to ensure that medicines and services are available when and where they are needed, at the local community level.
To help tackle this, Sandoz launched Sandoz HACk − Healthcare Access Challenge − to generate ideas and solutions with the power to make a tangible and impactful difference. For its inaugural year, Sandoz HACk encouraged young creative thinkers across the globe to share ideas that use mobile technology to connect people to better health.
From approximately 150 entries, six finalists have been chosen to submit their idea to our OpenIDEO community. Now we’re asking you to collaboratively strengthen these ideas, helping them achieve even greater impact.
Over the next six weeks, we ask that you take a look at the six ideas and provide your comments and feedback to help them evolve. The six finalists will then present their refined idea to a panel of judges at WIRED Health 2017 and the three most compelling ideas will win seed funding and mentorship to help make their idea a reality.
Healthcare access is still a major global issue for millions of people – be part of improving healthcare access by helping our finalists bring their ideas to life!
WHO: Health in 2015; Access to Medicine Index 2015
THE OPENIDEO CHALLENGE PROCESS
During our feedback phase, we’re asking you to share your comments, questions and thoughts to help strengthen and evolve our finalists’ ideas. Check out the six ideas in our Feedback phase and join a conversation. Leave your feedback and insights to help shape the evolution of each idea.
ABOUT OUR SPONSOR
Sandoz is a global leader in generic and biosimilar pharmaceuticals. As a division of the Novartis Group, their purpose is to discover new ways to improve and extend people’s lives. They contribute to society’s ability to support growing healthcare needs by pioneering novel approaches to help people around the world access high-quality medicine. Their portfolio of approximately 1000 molecules, covering all major therapeutic areas, accounted for 2015 sales of USD 10.1 billion. In 2015, their products reached more than 500 million patients and they aspire to reach one billion. Sandoz is headquartered in Holzkirchen, in Germany’s Greater Munich area.
Follow Sandoz on Twitter.
For more details visit www.sandoz.com/makingaccesshappen